Drug spending in the Italian national health service fell by 1% to 11.8 billion euros ($14.86 billion) in 2008 or 193.76 per capita of population. Figures from the pharmacy federation, Federfarma, indicate that against the downturn in spending, the number of scripts rose by 5.5% over the previous year to over 55 million or 9.4 a head.
Expenditure on pharmaceuticals jumped by 5.6% in the month of December, with an 11.5% rise in prescription volume as a flu epidemic gripped the country, together with the effect of an extra day in the month. Federfarma says the decline in spending is due to a reduction in the average value of a prescription - down by about 6.1% - as well as to the prescribing of lower-priced drugs. The average value per script was 12.58 euros last year compared with 13.12 euros in 2007. This continued decline in the value of prescriptions reflects official pricing policy since 2006 and the growing influence of reference prices in drug substitution.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze